Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The retinoblastoma (Rb) tumor suppressor controls cellular proliferation, survival, and differentiation and is functionally inactivated by mutations or hyperphosphorylation in most human cancers. Although activation of endogenous Rb is thought to provide an effective approach to suppress cell proliferation, long-term inhibition of apoptosis by active Rb may have detrimental consequences in vivo. To directly test these paradigms, we targeted phosphorylation-resistant constitutively active Rb alleles, RbΔKs, to the mouse mammary gland. Pubescent transgenic females displayed reduced ductal elongation and cell proliferation at the endbuds. Postpuberty transgenic mice exhibited precocious cellular differentiation and β-casein expression and extended survival of the mammary epithelium with a moderate but specific effect on the expression of E2F1, IGF1Rα, and phospho–protein kinase B/AKT. Remarkably, ∼30% RbΔK transgenic females developed focal hyperplastic nodules, and ∼7% exhibited full-blown mammary adenocarcinomas within 15 mo. Expression of the RbΔK transgene in these mammary tumors was reduced greatly. Our results suggest that transient activation of Rb induces cancer by extending cell survival and that the dual effects of Rb on cell proliferation and apoptosis impose an inherent caveat to the use of the Rb pathway for long-term cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The idea that RB could promote cancer under certain conditions by increasing survival is supported by experiments in transgenic mice expressing a phosphorylation-resistant, constitutively active allele of Rb in the mammary gland epithelium.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
In the citing paper
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnancy86.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724 · cited 1×
“However, as stated recently (Evan and Vousden, 2001) many growth deregulatory mutations have pleiotropic and tissue-specific effects on cell proliferation and apoptosis, and the therapeutic consequences of antiproliferative agents are thus difficult to predict.”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · cited 3×
“…Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit and cell survival (Dyson, 1998; Macleod, 1999; Harbour and Dean, 2000b).”
BackgroundInfluentialThe Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,408
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Similarly, a BCl2 transgene induces hyperplastic splenic follicles, which do not progress to B cell lymphoma in transgenic mice (McDonnell et al., 1989).”
BackgroundThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · cited 3×
“Mechanisms of precocious differentiation in MMTV-Rb K transgenic mice Although the role of Rb in cell proliferation and apoptosis is well established, it is not clear whether Rb affects terminal differentiation directly through interaction with differentiation factors or indirectly by allowing proper cell cycle exit a…”
BackgroundLundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067 · cited 4×
“Mitotic signals propagated through G1 cyclins induce sequential phosphorylation and inactivation of Rb (Lundberg and Weinberg, 1998).”
BackgroundInfluentialHarbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · cited 5×
“…to their resistance to phosphorylation by Cdks, the Rb Ks outperform wild-type Rb in multiple assays and are viewed as constitutively active, underphosphorylated, native Rb (Hamel et al., 1992; Geng et al., 1996; Knudsen et al., 1998; Sellers et al., 1998; Brown et al., 1999; Harbour et al., 1999).”
BackgroundInfluentialCyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934 · cited 2×
“In contrast to the MMTV/WAP-Rb K transgenic mice, cyclin D1–deficient mice do not succumb to mammary tumors but are rather protected from a subset of oncogenic pathways in the mammary gland (Sicinski et al., 1995; Yu et al., 2001b).”
BackgroundResult
Cited by
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
“Strikingly, these transgenic mice develop focal hyperplastic lesions and mammary tumours, probably because the survival of differentiated mammary epithelial cells is extended after pregnanc”
BackgroundThe retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
“Along these same lines, mice that express a 'hyperactive' Rb molecule (a mutated form of Rb that cannot be inactivated by phosphorylation) from the mouse mammary tumour virus (MMTV) promoter show reduced proliferation at the end buds, as well as precocious cellular differentiation and extended survival of the mammary…”
BackgroundCoordinated regulation of life and death by RB
Chau, B. N., & Wang, J. Y. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc993 · Cited by 292
“One-third of these mice developed hyperplastic nodules, and ∼7% of these mice developed adenocarcinoma”
BackgroundChinnam, M., & Goodrich, D. W. (2011) · Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00005-x · Cited by 199
“Consistent with this, constitutive activation of pRb in the mouse mammary gland initiates tumorigenesis (Jiang and Zacksenhaus, 2002).”
BackgroundThe retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
“This functional property predicts that pRb expression may be oncogenic, a prediction that has actually been verified under certain experimental conditions (Yamamoto et al., 1999; Jiang and Zacksenhaus, 2002; Borges et al., 2005).”
BackgroundOncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 173
“or instance, pRb was reported to enhance tumor cell survival y blocking apoptosis in a mammary tumor model [23], while oss of PTEN can cause senescence, raising the question whether art of the function of such TSGs is to protect cells from apoptois and/or senescence? This review article will discuss oncogenend TSG-med…”
BackgroundJiang, Z., Deng, T., Jones, R., Li, H., Herschkowitz, J. I., Liu, J. C., Weigman, V. J., Tsao, M.-S., Lane, T. F., Perou, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41490 · Cited by 148
Self-citationDasgupta, B., & Milbrandt, J. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.005 · Cited by 133
Chen, P.-L., Liu, F., Cai, S., Lin, X., Li, A., Chen, Y., Gu, B., Lee, E. Y.-H. P., & Lee, W.-H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3535-3542.2005 · Cited by 125
“It was reported that expression of a hypophosphorylated form of Rb in mice leads to breast carcinoma, perhaps through reducing apoptosis, with low incidence (17).”
BackgroundTumor Suppressors Having Oncogenic Functions: The Double Agents
Datta, N., Chakraborty, S., Basu, M., & Ghosh, M. K. (2020) · Cells · doi:10.3390/cells10010046 · Cited by 125
“feres with DNA synthesis and repair, resulting in an accumulation of damaged DNA and chromosomal abnormalities [52].”
BackgroundInfluentialRole of the RB Tumor Suppressor in Cancer
Yamasaki, L. (2006) · Cancer Treatment and Research · doi:10.1007/0-306-48158-8_9 · Cited by 84
Balasenthil, S., & Vadlamudi, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212822200 · Cited by 92
Newly identified aspects of tumor suppression by RB
Viatour, P., & Sage, J. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008060 · Cited by 94
“This idea that RB might be oncogenic in some contexts is substantiated by data in mice indicating that expression of a constitutively active form of RB in the mammary epithelium can promote cancer development (Jiang and Zacksenhaus, 2002).”
BackgroundFoxM1 Regulates Mammary Luminal Cell Fate
Carr, J. R., Kiefer, M. M., Park, H. J., Li, J., Wang, Z., Fontanarosa, J., DeWaal, D., Kopanja, D., Benevolenskaya, E. V., Guzman, G., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.005 · Cited by 90
“Also, virgin mice expressing a constitutively active form of Rb in the mammary gland undergo premature alveolar differentiation as evidenced by staining for markers of pregnancy (Jiang and Zacksenhaus, 2002).”
BackgroundDick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
Cell cycle proteins in epithelial cell differentiation: Implications for breast cancer
Caldon, C. E., Sutherland, R. L., & Musgrove, E. A. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11474 · Cited by 86
Role of cell‐cycle regulatory proteins in gynecological cancer
Milde‐Langosch, K., & Riethdorf, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10286 · Cited by 67
“In transgenic mice, which express a phosphorylation-resistant Rb allele in their mammary glands, normal ductal growth is reduced, but 30% of the females developed hyperplastic nodules and 7% exhibited mammary cancer (Jiang and Zacksenhaus, 2002).”
BackgroundHuang, H., Zegarra-Moro, O. L., Benson, D. D., & Tindall, D. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207326 · Cited by 58
“To determine whether activation of the RB protein affects expression of Bcl-2, LNCaP cells were transiently transfected with a constitutively active form of RB (RbDK11), in which 11 cyclin-dependent kinase (CDK)-regulated phosphorylation sites are mutated (Jiang and Zacksenhaus, 2002).”
BackgroundCoupling of caspase‐9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell‐type‐specific
Ho, A. T. V., Li, Q. H., Hakem, R., Mak, T. W., & Zacksenhaus, E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600039 · Cited by 56
“H&E and TUNEL assays, using biotin-dUTP, followed by DAB staining were performed as described (Jiang and Zacksenhaus, 2002).”
MethodSelf-citationLou, X., Zhang, J., Liu, S., Lou, X., & Liao, D. J. (2014) · Cell Cycle · doi:10.4161/cc.29082 · Cited by 51
“, the growth suppression of active RB1 protein imposes a selection pressure in favor of transforming mutations that accelerate cell proliferation.(107) Since RB1 regulates a plethora of genes that inhibit cell proliferation or promote apoptosis, besides those cell cycle-promoting genes such as CCNE1, CCNA2, and PCNA,(…”
Ciavarra, G., & Zacksenhaus, E. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201005067 · Cited by 53
“As control, transduction of a constitutively active, phosphomutant pRb (Ad.Rb; Jiang and Zacksenhaus, 2002) prevented collapse of Rb myotubes (not depicted) and, concomitantly, the accumulation of LC3-II by 1.”
Self-citationGene therapy for carcinoma of the breast
Stoff‐Khalili, M. A., Dall, P., & Curiel, D. T. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700929 · Cited by 46
“Several TSGs have already been shown to induce apoptosis or cause cell cycle arrest when introduced to breast cancer cells, including Rb”
BackgroundNoseda, M., Niessen, K. S., McLean, G. W., Chang, L., & Karsan, A. (2005) · Circulation Research · doi:10.1161/01.res.0000174380.06673.81 · Cited by 42
Caruso, J. A., Akli, S., Pageon, L. R., Hunt, K. K., & Keyomarsi, K. (2014) · Oncogene · doi:10.1038/onc.2014.284 · Cited by 46
“Rb and C/ EBPβ are essential to the control of proliferation and differentiation within the mammary gland (36, 37).”
BackgroundStromal Hoxa5 function controls the growth and differentiation of mammary alveolar epithelium
Garin, É., Lemieux, M., Coulombe, Y., Robinson, G. W., & Jeannotte, L. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20822 · Cited by 47
“For the -casein protein, incubation was 2 hr at room temperature (Jiang and Zacksenhaus, 2002).”
Conserved and specific functions of mammalian ssu72
St‐Pierre, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki171 · Cited by 39
“We therefore used as bait a constitutively active pRb allele, RbDK11, in which phosphorylation is inhibited by mutations in 11 of the 16 Ser/Thr phospho-acceptor sites in pRb (37).”
MethodMolecular signalling pathways in canine gliomas
Boudreau, C. E., York, D. S., Higgins, R. J., LeCouteur, R. A., & Dickinson, P. J. (2015) · Veterinary and Comparative Oncology · doi:10.1111/vco.12147 · Cited by 43
Impaired tight junction sealing and precocious involution in mammary glands ofPKN1transgenic mice
Fischer, A., Stuckas, H., Gluth, M., Russell, T. D., Rudolph, M. C., Beeman, N. E., Bachmann, S., Umemura, S., Ohashi, Y., Neville, M. C., et al. (2007) · Journal of Cell Science · doi:10.1242/jcs.03467 · Cited by 33
“Although the finding of a defect largely confined to this stage could reflect the hormone dependence of the MMTV promoter, numerous models using the same promoter display defects in either the virgin state or during pregnancy (Jager et al., 2003; Jiang and Zacksenhaus, 2002).”
BackgroundHow the other half lives, the amino‐terminal domain of the retinoblastoma tumor suppressor protein
Goodrich, D. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10358 · Cited by 33
“E2F1 is the first cellular protein identified as a binding partner for pRB (Helin et al., 1992; Kaelin et al., 1992; Shan et al., 1992).”
BackgroundEmerging strategies for the treatment of retinoblastoma
Deegan, W. F. (2003) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200310000-00010 · Cited by 30
von Willebrand, M., Zacksenhaus, E., Cheng, E., Glazer, P. M., & Halaban, R. (2003) · PubMed · Cited by 30
Self-citationPauciullo, A., & Erhardt, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124963 · Cited by 29
“Similar interactions are supposed also for the MyoD in the coindution of retinoblastoma tumor soppressor and β-casein for milk genes expression [52] and for Pbx1 in the synergic cross-talk with glucocorticoid receptors [53].”
BackgroundAndré, S., Pinto, A. E., Laranjeira, C., Quaresma, M., & Soares, J. (2007) · Pathobiology · doi:10.1159/000110025 · Cited by 28
Tumour-suppressor function in the nervous system
Baker, S. J., & McKinnon, P. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1297 · Cited by 31
Al‐Khalaf, H. H., Lach, B., Allam, A. A. K., Hassounah, M. I., Alkhani, A. M., Elkum, N. B., Alrokayan, S., & Aboussekhra, A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.074 · Cited by 23
Kim, K., Godarova, A., Seedle, K., Kim, M. H., Ince, T. A., Wells, S. I., Driscoll, J. J., & Godár, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080590 · Cited by 21
“Rb is known to inhibit cell differentiation [36], which is consistent with the de-differentiation-like phenotype in Rb knockdown cells, namely the decrease of luminal markers cytokeratins 8/18 and increase of basal markers p63 and cytokeratins 5/6 in vivo.”
ResultPauciullo, A., Shuiep, E. T. S., Ogah, D. M., Cosenza, G., Stasio, L. D., & Erhardt, G. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00748 · Cited by 21
“Analogous interactions are supposed for the MyoD transcription factor (Jiang and Zacksenhaus, 2002) and for Pbx1 in a synergic action with glucocorticoid receptors (Subramaniam et al., 2003).”
BackgroundGene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges
Sheikh‐Hosseini, M., Larijani, B. A., Kakroodi, Z. G., Shokoohi, M., Moarefzadeh, M., Sayahpour, F. A., Goodarzi, P., & Arjmand, B. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.199 · Cited by 26
“Some of these gene are BRCA1 , BRCA2 , p53 , Rb , 57,58 p16 , 59,60 p27 , 61 p21 , 62 Testin , 63 Maspin , 64 and melanoma differentiation-associated gene-7 ( mda7 ).”
Davison, E. A., Lee, C. S. L., Naylor, M. J., Oakes, S. R., Sutherland, R. L., Hennighausen, L. G., Ormandy, C. J., & Musgrove, E. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0199 · Cited by 20
“leads to precocious differentiation (26).”
Protein phosphatase 1α activity prevents oncogenic transformation
Liu, C. W. Y., Wang, R., & Berndt, N. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20191 · Cited by 23
“carcinomas in a conditional transgenic mouse model [53].”
BackgroundHypophosphorylated pRb knock‐in mice exhibit hallmarks of aging and vitamin C‐preventable diabetes
Jiang, Z., Li, H., Schroer, S. A., Voisin, V., Ju, Y., Pacal, M., Erdmann, N., Shi, W., Chung, P. E. D., Deng, T., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2020106825 · Cited by 19
“Thus, while endogenous/physiological levels of Rb Δ K7 and over-expression of wild-type pRb are well tolerated in certain cell types, over-expression of Rb Δ K11 with ◀ Figure 6 .”
InfluentialSelf-citationWęsierska‐Gądek, J., & Kramer, M. P. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.628985 · Cited by 17
“It seems that the presence of functional pRb protein is also essential for mammary gland differentiation [38].”
BackgroundCritical Role of the Rb Family in Myoblast Survival and Fusion
Ciavarra, G., Ho, A. T. V., Cobrinik, D. E., & Zacksenhaus, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017682 · Cited by 19
“Rb) [57] prevented degeneration of mgRb:Rb: p130 DKO myotubes (Fig.”
BackgroundSelf-citationDNA/RNA-based formulations for treatment of breast cancer
Xie, Z., & Zeng, X. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1317744 · Cited by 14
“Rb Regulation of cell proliferation, differentiation, and survival [24]”
BackgroundGene Therapy in the Treatment of Human Cancer
Annan, A. C., Fisher, P. B., Dent, P., Siegal, G. P., & Curiel, D. T. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_42 · Cited by 13
St-Pierre, B., Jiang, Z., Egan, S. E., & Zacksenhaus, E. (2004) · Gene Expression Patterns · doi:10.1016/j.modgep.2004.07.009 · Cited by 12
Self-citationLoss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
Akuma, M., Kim, M., Zhu, C., Wiljer, E., Gaudreau-Lapierre, A., Patterson, L. D., Egevad, L., Tanguay, S., Trinkle‐Mulcahy, L., Stanford, W. L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07623-y · Cited by 11
Wang, B., Hikosaka, K., Sultana, N., Sharkar, M. T. K., Noritake, H., Kimura, W., Wu, Y., Kobayashi, Y., Uezato, T., & Miura, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.014 · Cited by 10
Coordinated expression of Rb gene family in the mammary gland
Jiang, Z., & Zacksenhaus, E. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00089-3 · Cited by 10
Self-citationPanickar, K. S., Nonner, D., White, M. G., & Barrett, J. N. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9647-3 · Cited by 8
“Mutant Rb (Rb.K11) has 16 potential phosphoacceptor sites mutated and can not be fully phosphorylated [ 30 ].”
BackgroundSynthesising heterogeneity: trends of visuality in biological sciences circa 1970s - 2000s
Au, Y. (2016) · UCL Discovery (University College London) · Cited by 17
Monitoring the Cell Cycle of Tumor Cells in Mouse Models of Human Cancer
Hammond, T., & Sage, J. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041383 · Cited by 3
The p53 Independent Functions of Estrogen-Activated MDM2 in Cell Signaling and Mammary Architecture
Kundu, N. (2017) · CUNY Academic Works (City University of New York)
The Role of the Retinoblastoma Protein Family in Skeletal Myogenesis
Ciavarra, G. (2011) · Library and Archives Canada (Government of Canada)
Optimisation de l'immunothérapie non spécifique du cancer superficiel de la vessie
Ayari, C. (2012) · Corpus Université Laval (Université Laval)
New Insights into Transcriptional Regulation by Rb
Farnham, P. (2007) · Springer eBooks · doi:10.1007/0-387-33915-9_4
Metadata
- Authors
- Jiang, Z., & Zacksenhaus, E.
- Affiliations
- University Health Network (CA)
- Corresponding author
- Zacksenhaus, Eldad
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2002-01-03
- Volume
- 156
- Issue
- 1
- Pages
- 185-198
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2173568
- OpenAlex
- W2114749101
- Cited by
- 55
- References
- 83
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- retinoblastoma protein, mammary gland, mammary adenocarcinoma, apoptosis, cell proliferation, E2F1, IGF-1 receptor, Akt signaling, transgenic mice, tumor suppressor activation, cancer therapy
- MeSH terms
- Adenocarcinoma, Alleles, Animals, Breast, Cell Differentiation, Cell Division, Cell Survival, Female, Hyperplasia, Mammary Tumor Virus, Mouse, Mice, Transgenic, Milk Proteins, Models, Biological, Mutation, Parity, Phosphorylation, Pregnancy, RNA, Messenger, Mammary Neoplasms, Animal, Retinoblastoma Protein, In Situ Hybridization, Gene Expression Regulation, Developmental, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.